Acetazolamide cerebral blood flow

Dahl A, Russell D, Rootwelt KC et al (1995). Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow measurements dose serum concentration and time course of the response to acetazolamide. Stroke 26 2302-2306... [Pg.168]

The effect of acetazolamide on cerebral blood flow is underestimated with Tc-ECD (Dormehl et al. 1997). [Pg.262]

SPECT uses radionuclides, such as tedmetium-99m, rather than positron-emitters, such as carbon-11 or fluorine-18, as is the case with PET. A widely used SPECT radiopharmaceutical is technetium-99m hexamethylpropylene amine oxime, to measure regional cerebral blood flow after systemic administration of the cerebral vasodilator acetazolamide (aceta-zolamide test) to patients with Alzheimer s disease (AD) or vascular dementia (VD). [Pg.144]

Big Chemical Encyclopedia